Intravenous longevity therapy

1 paper2 findings

Outcomes

2

Fatigue syndromes

downin reviews1

1 study

Intravenous longevity therapy decreases fatigue syndromes.
“modest improvements in fatigue syndromes”
Reviewfatigue syndromes
Intravenous longevity therapy: a critical review of evidence, mechanisms, and clinical utility
Acta dermatovenerologica Alpina, Pannonica, et Adriatica1 Mar 2026

More on Fatigue syndromes

Oxidative biomarkers

downin reviews1

1 study

Intravenous longevity therapy decreases oxidative biomarkers.
“reports transient reductions in oxidative biomarkers”
Reviewintravenous administration
Intravenous longevity therapy: a critical review of evidence, mechanisms, and clinical utility
Acta dermatovenerologica Alpina, Pannonica, et Adriatica1 Mar 2026

More on Oxidative biomarkers

Latest

1 in 12 months

Acta Dermatovenerologica Alpina, Pannonica, et Adriatica31 Mar

Intravenous longevity therapy: a critical review of evidence, mechanisms, and clinical utility

ReviewInterventions